<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04131283</url>
  </required_header>
  <id_info>
    <org_study_id>1/2019</org_study_id>
    <nct_id>NCT04131283</nct_id>
  </id_info>
  <brief_title>Evidence of Spreading Vasoconstriction in Human Gingiva</brief_title>
  <official_title>Evidence of Spreading Vasoconstriction in Human Gingiva</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Semmelweis University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Semmelweis University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to observe the mechanism of spreading vasoconstriction in human
      healthy gingiva. Epinephrine solution is applied on the attached gingiva in group &quot;A&quot; and on
      the surface of the tooth next to the ginvial sulcus in group &quot;B&quot;. The different placement of
      the solution causes different effect in the microcirculation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Spatial regulation of gingival microcirculation has not been revealed yet. Although this
      could be an important mechanism to protect gingiva as it is exposed to mechanical, chemical,
      thermal etc. irritation during whole life. It is especially important during flap surgery.
      Laser Speckle Contrast Imaging (LSCI) is novel non-invasive method with high spatio-temporal
      resolution, therefore it allows us to study remote effect of local vasoconstriction such as
      spreading vasoconstriction in human gingiva.

      The epinephrine is a daily used vasoconstrictor material in dentistry and it will be used to
      trigger remote effect on gingiva. Epinephrine in 1 mg/ml concentration. Solution will be
      dropped on the gingiva at tooth 12 in a fabricated leakage proof well attached to 2mm above
      the marginal gingiva in group &quot;A&quot;. The solution will be dropped on the surface of tooth 12
      next to the sulcus into the well in case of group &quot;B&quot;. The changes of the blood flow will be
      monitor at the test side with surrounding gingival area by LSCI. The control side in each
      case will be - appropriately to the test side - at tooth 21 with phisiologocal saline.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Actual">January 1, 2020</completion_date>
  <primary_completion_date type="Actual">December 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood flow change after application of epinephrine</measure>
    <time_frame>30 minutes</time_frame>
    <description>The change in blood flow will be measured after locally applied epinephrine at the site fo application and at the remote sites</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparsion of the change in blood flow between genders</measure>
    <time_frame>30 minutes</time_frame>
    <description>The maximal blood flow changed assessed in primary outcome will be split into two groups based on gender. The change will be compared between males and females.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Correlation between the change in blood flow and gingival thickness</measure>
    <time_frame>5 minutes</time_frame>
    <description>The biotpye will be assessed by measurement of gingival thickness by an ultrasonic devices. The correlation between thickness and maximal vasodilation will be evaluated.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">29</enrollment>
  <condition>Vasoconstriction</condition>
  <condition>Oral Soft Tissue Conditions</condition>
  <condition>Dental and Gingival Conditions</condition>
  <arm_group>
    <arm_group_label>Epinephrine effect throught keratinized ginigva</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 mg/ml epniephrine vs physiologocal saline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Epinephrine effect throught gingival sulcular epithelium</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 mg/ml epniephrine vs physiologocal saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Epinephrine</intervention_name>
    <description>Vasoconstrictor solution is applied on the surface of the attached gingiva and on the gingival sulcus.</description>
    <arm_group_label>Epinephrine effect throught gingival sulcular epithelium</arm_group_label>
    <arm_group_label>Epinephrine effect throught keratinized ginigva</arm_group_label>
    <other_name>retrograde vasoconstriction</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  at least 5 mm keratinized gingiva at the upper front teeth

          -  general health

        Exclusion Criteria:

          -  pregnancy, breast-feeding

          -  any medication

          -  smoking, gingivitis, caries and coronal restoration with insufficient marginal
             integrity
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Janos Vag</name>
      <address>
        <city>Budapest</city>
        <zip>1088</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>October 16, 2019</study_first_submitted>
  <study_first_submitted_qc>October 16, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 18, 2019</study_first_posted>
  <last_update_submitted>July 1, 2020</last_update_submitted>
  <last_update_submitted_qc>July 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Semmelweis University</investigator_affiliation>
    <investigator_full_name>Dr. Vag Janos</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>spreading vasoconstriction</keyword>
  <keyword>gingival microcirculation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epinephrine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

